Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stephen Ryu

Neurological Surgery Stanford, CA Medical Doctor

NPI 1134153505 CMS profile 277939

300 Pasteur Dr, Stanford, CA 94305

Open in the dashboard

General payments

$847,452

847 records reported · program years 2019–2025

Research payments

$5,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$1,271,468

11 holdings reported · through program year 2025

Through program year 2025, Stephen Ryu of Stanford, CA is reported in the CMS Open Payments database as having received $847,452 across 847 general payments and $5,000 in research payments paid to them. They also declared ownership or investment interests valued at $1,271,468 across 11 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

15 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $85,212 59
2024 General $112,470 121
2023 General $150,233 151
2022 General $149,042 130
2022 Research $5,000 1
2021 General $79,630 87
2020 General $85,236 75
2019 General $185,628 224
2025 Ownership $256,669 2
2024 Ownership $256,669 2
2023 Ownership $218,306 2
2022 Ownership $209,956 2
2021 Ownership $109,956 1
2020 Ownership $109,956 1
2019 Ownership $109,956 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Ryu
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Stephen Ryu were reported at $85,212. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Stephen Ryu Neurological Surgery median Middle half National median
2019 $185,628 $582 $138–$3,006 $163
2020 $85,236 $294 $76–$2,174 $114
2021 $79,630 $387 $105–$2,432 $132
2022 $149,042 $542 $139–$2,989 $149
2023 $150,233 $534 $145–$2,697 $160
2024 $112,470 $574 $155–$3,046 $164
2025 $85,212 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuVasive, Inc. $356,985 323 payments
  2. Stryker Corporation $171,695 141 payments
  3. Globus Medical, Inc. $132,322 99 payments
  4. Zimmer Biomet Holdings, Inc. $51,116 66 payments
  5. Zimvie Inc. $37,723 65 payments
  6. Medtronic, Inc. $26,198 45 payments
  7. Medical Device Business Services, Inc. $20,614 11 payments
  8. SI-BONE, Inc. $18,333 16 payments
  9. Highridge Medical LLC $16,650 18 payments
  10. DePuy Synthes Products, Inc. $9,097 16 payments
  11. Other $6,719 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $499,601 173 payments
  2. Royalty or License $216,792 24 payments
  3. Travel and Lodging $92,707 320 payments
  4. Food and Beverage $23,751 326 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,800 3 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,800 1 payment
Products named General payments · program years 2019–2025
  1. Pulse Spine/Spine Surgery $243,811 101 payments
  2. NVM5 $142,524 12 payments
  3. LessRay $138,315 10 payments
  4. Pulse Spine/Spine Surgery $74,607 92 payments
  5. TRITANIUM $68,912 24 payments
  6. SERRATO $57,536 19 payments
  7. Simplify Cervical Artificial Disc $56,962 49 payments
  8. AIRO $47,617 4 payments
  9. Mobi-C $45,911 57 payments
  10. ES2 $38,685 16 payments
  11. Other $561,498 522 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. DuraStat LLC $5,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

28

Median for Neurosurgery: 83

Drug cost

$551

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 28 $551

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$293,679

Medicare's payments for the services billed

Medicare patients

469

Average age 76

Services billed

1,023

236 women, 233 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 69%
High blood pressure 67%
Ischemic heart disease 30%
Osteoporosis 25%
Diabetes 21%
Chronic kidney disease 19%
Depression 19%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

848 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record